# Creative Medical Technology Holdings Inc. (CELZ)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $5M  
**Price:** $2.11 (-3.21%)

> Creative Medical Technology Holdings Inc. is a biotechnology company dedicated to advancing regenerative medicine and immune-based therapies. The company's primary focus is on developing therapeutic solutions that address significant unmet medical needs, especially in the fields of immunology, hematology, and neurology. Creative Medical Technology Holdings Inc. leverages cutting-edge research in stem cell technology and uses it to develop innovative treatments that have the potential to revolutionize patient care across multiple medical disciplines.

The company is active in pioneering treatments for degenerative diseases and aims to translate scientific advancements into clinical applications that improve patient outcomes. Creative Medical Technology Holdings Inc. plays a crucial role in the biotech sector by contributing to advancements in regenerative medicine, which is seen as a promising frontier for developing therapies that go beyond conventional medicine. As it continues its research and development activities, it holds a significant position within the healthcare and life sciences markets, impacting various industries devoted to improving human health and wellness.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $6,000 | $3,806 | -$6M | -$6M | $-2.52 |
| 2024 | $11,000 | $6,600 | -$6M | -$5M | $-3.71 |
| 2023 | $9,000 | $5,400 | -$6M | -$5M | $-3.76 |
| 2022 | $88,600 | $60,109 | -$10M | -$10M | $-9.28 |
| 2021 | $87,754 | $39,805 | -$3M | $19M | $140.25 |
| 2020 | $164,500 | $113,904 | -$1M | -$36M | $-626.90 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $8M | $284,880 | $8M | $7M | — |
| 2024 | $7M | $327,644 | $6M | $6M | — |
| 2023 | $11M | $371,394 | $10M | $3M | — |
| 2022 | $19M | $3M | $16M | $8M | — |
| 2021 | $11M | $1M | $10M | $11M | — |
| 2020 | $717,775 | $41M | -$40M | $98,012 | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$6M | — | -$6M |
| 2024 | -$5M | — | -$6M |
| 2023 | -$8M | — | -$8M |
| 2022 | -$7M | — | -$8M |
| 2021 | $24M | — | -$2M |
| 2020 | -$35M | — | -$684,556 |

Source: [CompaniesByCap](https://companiesbycap.com/company/CELZ)